Illumina Creates Business Unit to Focus on Clinical Market
January 11, 2012
Illumina Creates Business Unit to Focus on Clinical Market
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina in Discussions with 100 Potential Clinical Customers for MiSeq, Plans Cancer Diagnostics
April 25, 2012 / Clinical Sequencing News - NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News - Asuragen Launches Cancer Panels Optimized for FFPE Tissue; Plans to Sell Proprietary Reagents
April 10, 2013 / Clinical Sequencing News - Illumina Focuses on Reproductive Health; May Modify MiSeq/HiSeq for Different Clinical Needs
January 30, 2013 / Clinical Sequencing News - Oxford Group Launches PGM-Based Cancer Test under UK's Stratified Medicine Program
January 2, 2013 / Clinical Sequencing News